Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Beyond migraine headache day reduction: Clinically meaningful improvement in disability (MIDAS score) in the absence of greater than 50% reductions in monthly migraine days with galcanezumab

              Author:Vargas, Bert   Starling, Amaal   Nicholson, Robert   Polavieja, Pepa   Katsarava, Zaza   Viktrup, Lars   Vincent, Maurice   Lipton, Richard   

              Session Name:P10: Headache: Towards Precision Medicine 1  

              Topic:Headache  

              Program Number:P10.008  

              Author Institution:Eli Lilly & Company, Indianapolis, IN  Mayo Clinic, Scottsdale, AZ  Eli Lilly & Company, Madrid, Spain  University of Essen, Unna, Germany  Albert Einstein College of Medicine, Bronx, NY